ARCTURUS THERAPEUTICS HOLDINGS INC. Total Liabilities
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Total Liabilities of $52.50 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-06
- 2026-06-30: Liabilities $52.50M.
- 2026-03-31: Liabilities $54.05M.
- 2025-12-31: Liabilities $57.16M.
- 2025-09-30: Liabilities $57.78M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $52.50M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $54.05M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $57.16M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $57.78M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $78.22M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $98.03M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $103.09M 10-K · filed 2026-03-03 |
| 2024-09-30 | $108.79M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $130.03M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $154.88M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $150.89M 10-K · filed 2025-03-06 |
| 2023-09-30 | $177.59M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $145.47M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $141.62M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $180.07M 10-K · filed 2024-03-14 |
| 2022-09-30 | $147.96M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $166.30M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $157.24M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $164.60M 10-K · filed 2023-03-29 |
| 2021-09-30 | $175.41M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $143.16M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $128.86M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $79.90M 10-K · filed 2022-03-01 |
| 2020-09-30 | $60.89M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $56.51M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $55.12M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $56.35M 10-K · filed 2021-03-01 |
| 2019-09-30 | $51.32M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $49.32M 10-Q · filed 2019-08-14 |
| 2018-12-31 | $30.56M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |